104
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Low Concentrations of Dehydroepiandrosterone Sulfate are Associated with Depression and Fatigue in Patients with Non-Small-Cell Lung Cancer After Chemotherapy

ORCID Icon, ORCID Icon, , ORCID Icon, , , & show all
Pages 2103-2109 | Published online: 17 Sep 2020

References

  • Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1).
  • Takano N, Ariyasu R, Koyama J, et al. Improvement in the survival of patients with stage IV non-small-cell lung cancer: experience in a single institutional 1995–2017. Lung Cancer. 2019;131:69–77. doi:10.1016/j.lungcan.2019.03.00831027701
  • Vodermaier A, Lucas S, Linden W, et al. Anxiety after diagnosis predicts lung cancer-specific and overall survival in patients with stage III non-small cell lung cancer: a population-based cohort study. J Pain Symptom Manage. 2017;53(6):1057–1065. doi:10.1016/j.jpainsymman.2016.12.33828063862
  • Doroshow DB, Herbst RS. Treatment of advanced non-small cell lung cancer in 2018. JAMA Oncol. 2018;4(4):569–570. doi:10.1001/jamaoncol.2017.519029494728
  • Stone P, Richards M, A’Hern R, et al. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000;11(5):561–568. doi:10.1023/A:100833123060810907949
  • Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28. doi:10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-611180574
  • Park B, Youn S, Yi -K-K, et al. The prevalence of depression among patients with the top ten most common cancers in South Korea. Psychiatry Investig. 2017;14(5):618–625. doi:10.4306/pi.2017.14.5.618
  • Pearce A, Haas M, Viney R, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. PLoS One. 2017;12(10):e0184360. doi:10.1371/journal.pone.018436029016607
  • Walling AM, Weeks JC, Kahn KL, et al. Symptom prevalence in lung and colorectal cancer patients. J Pain Symptom Manage. 2015;49(2):192–202. doi:10.1016/j.jpainsymman.2014.06.00324973624
  • Bower JE. The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms. Cancer. 2019;125(3):353–364. doi:10.1002/cncr.3179030602059
  • Young K, Singh G. Biological mechanisms of cancer-induced depression. Front Psychiatry. 2018;9:299. doi:10.3389/fpsyt.2018.0029930042700
  • Rutkowski K, Sowa P, Rutkowska-Talipska J, et al. Dehydroepiandrosterone (DHEA): hypes and hopes. Drugs. 2014;74(11):1195–1207. doi:10.1007/s40265-014-0259-825022952
  • Fischli S, Jenni S, Allemann S, et al. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2008;93(2):539–542. doi:10.1210/jc.2007-178017986637
  • Lissoni P, Rovelli F, Giani L, et al. Dehydroepiandrosterone sulfate (DHEAS) secretion in early and advanced solid neoplasms: selective deficiency in metastatic disease. Int J Biol Markers. 1998;13(3):154–157. doi:10.1177/17246008980130030610079390
  • Bhatavdekar JM, Patel DD, Chikhlikar PR, et al. Levels of circulating peptide and steroid hormones in men with lung cancer. Neoplasma. 1994;41(2):101–103.8208311
  • Nishio M, Ohyanagi F, Horiike A, et al. Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients. Br J Cancer. 2005;92(10):1877–1880. doi:10.1038/sj.bjc.660258515870715
  • Ettinger DS, Wood DE, Aggarwal C, et al. NCCN guidelines insights: non-small cell lung cancer, version 1.2020. J Natl Compr Canc Netw. 2019;17(12):1464–1472. doi:10.6004/jnccn.2019.005931805526
  • Edge SB, Compton CC. The American Joint Committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:10.1245/s10434-010-0985-420180029
  • de Kock I, Mirhosseini M, Lau F, et al. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. J Palliat Care. 2013;29(3):163–169. doi:10.1177/08258597130290030524380215
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x11556941
  • Bellon Saameno JA, Delgado Sánchez A, Luna Del Castillo JD, et al. [Validity and reliability of the family Apgar family function test]. Aten Primaria. 1996;18(6):289–296.[Article in Spanish]8983381
  • Meltzer-Brody S, Churchill E, Davidson JR. Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder. Psychiatry Res. 1999;88(1):63–70. doi:10.1016/S0165-1781(99)00070-010641587
  • Chen CH, Shen WW, Tan HK-L, et al. The validation study and application of stratum-specific likelihood ratios in the Chinese version of SPAN. Compr Psychiatry. 2003;44(1):78–81. doi:10.1053/comp.2003.5001312524640
  • Chang TJ, Tarn Y-H, Hsieh C-L, et al. Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population. J Formos Med Assoc. 2007;106(12):1023–1031. doi:10.1016/S0929-6646(08)60078-918194908
  • Lin CC, Chang A-P, Chen M-L, et al. Validation of the Taiwanese version of the brief fatigue inventory. J Pain Symptom Manage. 2006;32(1):52–59. doi:10.1016/j.jpainsymman.2005.12.01916824985
  • Tzeng JI, Fu YW, Lin CC. Validity and reliability of the Taiwanese version of the Pittsburgh sleep quality index in cancer patients. Int J Nurs Stud. 2012;49(1):102–108. doi:10.1016/j.ijnurstu.2011.08.00421924421
  • Lee Y, Wu Y-S, Chien C-Y, et al. Use of the hospital anxiety and depression scale and the Taiwanese depression questionnaire for screening depression in head and neck cancer patients in Taiwan. Neuropsychiatr Dis Treat. 2016;12:2649–2657. doi:10.2147/NDT.S11206927789953
  • van Leeuwen RW, Peric R, Hussaarts KGAM, et al. Influence of the acidic beverage cola on the absorption of erlotinib in patients with non-small-cell lung cancer. J Clin Oncol. 2016;34(12):1309–1314. doi:10.1200/JCO.2015.65.256026858332
  • Charoensri S, Chailurkit L, Muntham D, et al. Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis. J Clin Transl Endocrinol. 2017;7:42–46. doi:10.1016/j.jcte.2017.01.00129067249
  • Strasser F, Palmer JL, Schover LR, et al. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer. 2006;107(12):2949–2957. doi:10.1002/cncr.2233917103445
  • Souza-Teodoro LH, de Oliveira C, Walters K, et al. Higher serum dehydroepiandrosterone sulfate protects against the onset of depression in the elderly: findings from the English Longitudinal Study of Aging (ELSA). Psychoneuroendocrinology. 2016;64:40–46. doi:10.1016/j.psyneuen.2015.11.00526600009
  • Schmidt PJ, Daly RC, Bloch M, et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005;62(2):154–162. doi:10.1001/archpsyc.62.2.15415699292
  • Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison’s disease in a randomized, double blind trial. J Clin Endocrinol Metab. 2000;85(12):4650–4656. doi:10.1210/jcem.85.12.702211134123
  • Peixoto C, Devicari Cheda J, Nardi A, et al. The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review. Curr Drug Targets. 2014;15(9):901–914. doi:10.2174/138945011566614071711111625039497
  • Berger AM, Mooney K, Alvarez-Perez A, et al. Cancer-related fatigue, version 2.2015. J Natl Compr Canc Netw. 2015;13(8):1012–1039. doi:10.6004/jnccn.2015.012226285247
  • Scott HR, McMillan DC, Forrest LM, et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer. 2002;87(3):264–267. doi:10.1038/sj.bjc.660046612177792
  • Morrison MF, Ten Have T, Freeman EW, et al. DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years. Biol Psychiatry. 2001;50(9):705–711. doi:10.1016/S0006-3223(01)01169-611704078
  • Barrett-Connor E, von Mühlen D, Laughlin GA, et al. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc. 1999;47(6):685–691. doi:10.1111/j.1532-5415.1999.tb01590.x10366167
  • Kurita H, Maeshima H, Kida S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord. 2013;146(2):205–212. doi:10.1016/j.jad.2012.09.00423102506